The compound in question is epigallocatechin-3-gallate (EGCG). A great deal of research has focused on this promising polyphenolcompound, revealing its impressive anti-inflammatory effects as well as its compelling quality to act as a protective element against neuronal damage. Some Alzheimer’s research has focused on EGCG’s ability to inhibit the formulation of amyloid plaques in the brain.
This new study set out to examine how EGCG affects the amyloid deposits that can build up in arteries. Atherosclerosis is a cardiovascular disease that involves formations of amyloid deposits in blood vessels that can lead to heart attack or stroke. These deposits are similar to those that are associated with Alzheimer’s disease.
(To view entire article visit: https://newatlas.com/green-tea-heart-disease-prevention/54885/)